Faculty

Journals Publications

• “Design, Synthesis and Biological Evaluation of Anti-Tuberculosis / Anti-HIV activity of some novel substituted Oxadiazole derivatives.” Proposed to Chhattisgarh Council of Science & Technology

Patent Published

• In silico screening, physicochemical &pharmacokinetic analysis of novel sulphonamides as potential antimicrobial drugs docked with protein targets: PDB: 2VF5, 1KZN & 1JIJ, Patent No. 2021105099, Publication Date: 29-09-2021, Status:Granted(Australian Patent)
• An integrated system of image recognitionition along with artificial intelligence for accurate prediction of lung cancer using various medical modalities.(Indian patent)
• fast dissolving oral composition of Etodolac and preparation thereof.(Indian patent)

Journals Publications

• Richie R Bhandare , Chandrashekar S.Munikrishnappa , G.V. Suresh Kumar , Sathish Kumar Konidala , Dilep Kumar Sigalapalli , Yogesh Vaishnav , Sampath Chinnam , Haya Yasin , Ahmed A. Al-karmalawy , Afzal B. Shaik. “Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents, Journal of Saudi Chemical Society 2022 (26), 101447, ISSN 1319-6103, https://doi.org/10.1016/j.jscs.2022.101447.
• Santosh Kumar Verma, Rameshwari Verma, Yarabahally R. Girish, Fan Xue, Long Yan, Shekhar Verma Monika Singh, Yogesh Vaishnav, Afzal B. Shaik, Richie R. Bhandare, Kadalipura P. Rakesh, Kothanahally S. Sharath Kumar and Kanchugarakoppal S. Rangappa. “Heterogeneous graphitic carbon nitrides in visible-light-initiated organic transformations, Green Chemistry, 2022, ISSN 1463-9270, https://doi.org/10.1039/D1GC03490A.
• Rameshwari Verma, Santosh K Verma, Vandana Verma, Shekhar Verma, Yogesh Vaishnav, Vinod Jena, Amit Kumar, KP Rakesh” Catalytic pyrolysis of ulva lactuca macroalgae: Effects of mono and bimetallic catalysts and reaction parameters on bio-oil up-gradation, Bio Resource Technology, 2021, Volume 324, March 2021, 124594, ISSN 0960-8524, https://doi.org/10.1016/j.biortech.2020.124594.
• Santosh Kumar Verma, Rameshwari Verma, Shekhar Verma, Yogesh Vaishnav, SP Tiwari, KP Rakesh “Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review”European Journal Of Medicinal Chemistry, 2021/1/1, Volume 209, 112886, ISSN 0223-5234, https://doi.org/10.1016/j.ejmech.2020.112886.
• Yogesh Vaishnav,Dhansay Dewangan,Shekhar Verma,Achal Mishra,Alok Singh Thakur,Pranita Kashyap,Santosh Kumar Verma “PPAR gamma targeted molecular docking and synthesis of some new amide and urea substituted 1, 3, 4-thiadiazole derivative as antidiabetic compound”Journal of Heterocyclic Chemistry, 04 March 2020, Volume 57, 2213-2224,ISSN 1943-5193, https://doi.org/10.1002/jhet.3941.
• D Dewangan, Y Vaishnav, A Mishra, AK Jha, S Verma, H Badwaik “Synthesis, molecular docking, and biological evaluation of Schiff base hybrids of 1,2,4-triazole-pyridine as dihydrofolate reductase inhibitors” Current Research in Pharmacology and Drug Discovery, 2021/1/1, Volume 2, 100024ISSN 2590-2571, https://doi.org/10.1016/j.crphar.2021.100024.
• Achal Mishra, Yogesh Vaishnav, Arvind Kumar Jha, Shekhar Verma “3D QSAR analysis on quinoxaline derivatives as anti-malarial using K-nearest neighbour molecular field analysis” Indian Journal of Chemistry-Section B (IJC-B), 2021/6/29, Volume 60, 727-731, ISSN 0975-0983.
• Yogesh Vaishnav, Aloksingh Thakur, Chanchal Deep Kaur, Shekhar Verma, Achal Mishra, Sanmati Kumar Jain, Piyush Ghode“QSAR Analysis of some N, N-diphenyl urea derivatives as CCR5 Receptor Antagonist” Research Journal of Pharmacy and Technology2018, Volume 11, 3802-3810, ISSN 0974-3618.
• Yogesh Vaishnav, Pranita Kashyap, Chanchal Deep Kaur, “3D QSAR Analysis on 2piperidinopiperidinethiadiazole Derivatives as Histamine H3 Receptor Inhibitors” Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 2017/4/1, Volume 7, 59-66, ISSN 2468-1881.
• Shekhar Verma, Yogesh Vaishnav, Santosh K Verma, Arvind K Jha “Anhydrous Nanoemulsion: An Advanced Drug Delivery System for Poorly Aqueous Soluble Drugs” Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 2017/4/1, Volume 7, 36-46, ISSN 2468-1881
• Yogesh Vaishnav, Pranita Kashyap, Chanchal Deep Kaur, “An approach to design potent anti-diabetic agents by 3D QSAR studies on substituted thiadiazole derivatives using kNN –MFA methodology” Indian Journal of heterocyclic chemistry, 2016/10/1 Volume 26, 185-194, ISSN 2456-4311.
• Yogesh Vaishnav, Arvind Kumar Jha, Shekhar Verma, Pranita Kashyap, Chanchal Deep Kaur“ A review on anti-diabetic activity of substituted 1,3,4- Thiadiazole derivatives” Research Journal of Pharmacy and Technology, 2017Volume 10, 4467-4470,ISSN 0974-3618.
• Yogesh Vaishnav, Arpan Tripathi, Isha sonkar“Electrolytes effervescent tablets- A review “ Journal of Cardiovascular Disease Research, 2021, ISSN 0975-3583.
• Gunjan Kalyani, D Sharma, Y Vaishnav, VS Deshmukh “A review on drug designing, methods, its application and prospects”International journal of pharmaceutical research and development , 2013, Volume 5, 015-0, ISSN 0974-9446.
• Gunjan Kalyani*, Vishal S Deshmukh, Yogesh Vaishanv and Pranita Kashyap, “Analytical method development and validation for the estimation of candesartan by derivative spectroscopy (first order and second order)”International Journal OfPharmaceutical Sciences And Research, 28 April, 2012, Volume 25, 1379-1384, ISSN 0975-8232, http://dx.doi.org/10.13040/IJPSR.0975-8232.3(5).1379-84.
• Laxmi Banjare, Yogesh Vaishnav, Pranita Kashyap, “Synthesis and biological evaluation of 3-chloro 2- methyl phenyl carbamoyl substituted semicarbazone derivatives as potential anticonvulsant agents” International journal of Pharma sciences and research (IJPS) 2012, Volume 03, 226-240, ISSN 0975-9492.
• Devendra Singh Thakur, Harish Rajak, Peeyush Kumar, Yogesh Vaishnav, “Synthesis of some novel 4-(4-chlorophenyl)-6-p-tolyl" pyrimidine derivatives and their anticonvulsant activity”Acta Pol Pharm, 2011/11/1, Volume 68, 993-97, ISSN 0001-6837.
• Govind Sharma, Arvind Jha, Ajjazuddin, Yogesh Vaishnav, Arpan Tripathi“2D QSAR analysis on substituted pyrrolidine derivatives as Dipeptidyl peptidase-IV inhibitors” Journal of Cardiovascular Disease Research,2021, ISSN 0975-3583.
• Govind Sharma, Arvind Jha, Ajjazuddin, Yogesh Vaishnav, Arpan Tripathi“3D QSAR analysis on substituted pyrrolidine derivatives as Dipeptidyl peptidase-IV inhibitors” Journal of Cardiovascular Disease Research,2021, ISSN 0975-3583.
• Yogesh Vaishnav, Laxmi Banjare, Shekhar Verma, “Computational Method on Hydroxychloroquine and Azithromycin for SARS-CoV-2: Binding Affinity Studies , RJPT, 2021, ISSN 0974-3618.

Conferences/ Seminars

• Yogesh Vaishnav, “3D QSAR analysis on substituted oxadiazolines derivatives as potent Anti HIV agents” 2022, International conference on recent advances in biological sciences & opportunities in entrepreneurship, 7-8 January 2022,School of Studies in Biotechnology, Pt. Ravishankar Shukla University, Raipur.

Awards/Recognitions

• Chairman in Scientific session "Current Perspectives of Pharmacovigilance in Drug Discovery and Development"., International Conference (ICCPPDD 2022) on 7th - 8th April 2022 , Kalinga University, Raipur.

Training Programmes/Workshops Attended

1. Three days Faculty development program on “Leveraging Future: Research Writing & Entrepreneurship” organized by Indian Institute of Management(IIM) Raipur & CSVTU Bhilai.
2. Five Day Faculty Development Programme (e-FDP) on “Restructuring Pharmacy Education for Atmanirbhar Bharat: Time for Transformation” organized by Lloyd Institute of Management &Technology, Delhi.
3. Six days Faculty development program on Outcome based education and Accreditation, organized by AICTE Margdarshan scheme and organied by BIT Durg .C.G.
4. Three days continuing Educational Programs on “Academics, Research and Outcome Implementation”Sponsored by PCI and organized by SRIP Kumhari Durg. C.G.
5. Fifteen days Faculty development program on “Recent advances in designing of novel formulation for plant actives and extracts” organized by UIOP, Pt.Ravishankar Shukla University Raipur.
6. Fifteen days National field survey of spurious drugs organized by Food & Drug Administration, Govt. of Chhattisgarh, India.

Membership to Professional Bodies

• Member Secretary in CPCSEA (Committee for the Purpose of Control and Supervision of Experiments on Animals, Govt. Of India).
• Approved CSVTU inspector.